Coagulation Diagnostics Incorporated

Coagulation Diagnostics, Inc. (CDI) develops proprietary diagnostic tests for hypercoagulability, or the tendency to form blood clots. The primary applications for the Company's diagnostic tests include monitoring of novel anticoagulants, assessing the risk of acute myocardial infarction, diagnosing possible reactivation of ischemia, and assessing the risk of clotting following invasive cardiovascular diagnostic procedures or cardiovascular surgery. The Company's flagship products, which are in clinical development, are called HepStatTM, the Tissue Factor Clotting Time (TiFaCTTM) and the Tissue Factor Antibody Assay (TiFAbTM). CDI also holds rights to certain other technologies, including silicon microcantilevers that may be designed to measure a patient's full coagulation profile.

Contact Details: 4600 East-West Highway Bethesda MD 20814 United States of America Tel: 240-497-0910 Fax: 240-497-0911 Email: jmcdonnell@coagdiag.com WWW: www.coagdiag.com/CNRS-bioMerieux/

Loading...

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 511 times since April 2007, the link to the organisation's website has been followed 114 times

Recent Search Terms used to find this page: coagulation diagnostics biomerieux | coagulation diagnostics | cdi blood not clotting | coagulation diagnostics inc | Coagulation Diagnostic | Coagulations Diagnostics Inc | COAGULATION PROFILE IN AMI | coagulation diagnostics | Coagulation Diagnostics | coagulation diagnostics inc | .

Search for more companies in Bethesda

Search for more companies in MD

This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for Coagulation Diagnostics Incorporated